Novo Nordisk director defends Wegovy prices on US TV amid fresh criticism

Speaking on on NBC’s Nightly News on Monday, Lars Fruergaard Jørgensen said that the high price of the weight loss medicine in America should be seen in the light of its benefits to users.

Administrative Director at Novo Nordisk Lars Fruergaard Jørgensen. Photo: Novo Nordisk

Ahead of a hearing in the US Senate, the administrative director of Novo Nordisk Lars Fruergaard Jørgensen has once again defended against accusations that the Danish drugmaker is charging extortionate prices for its popular weightloss medicine Wegovy in the US.Fruergaard Jørgensen appeared on NBC’s Nightly News which aired on US TV on Monday night Danish […]


Gain unlimited access to all of The Copenhagen Post

Our independent reporting can only be published with support from our readers.

Monthly subscription

119

DKK/month.

(Billed once a month)

Give us a try

6 month subscription

99

DKK/month.

(Billed twice a year)

Save 120 DKK

Yearly subscription

79

DKK/month.

(Billed once a year)

Save 480 DKK

Save with a company subscription?




Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.